One Health: The global challenge of epidemic and endemic leishmaniasis

Parasites and Vectors

Volumn 4, Issue 1, 2011, Pages

  Palatnik De Sousa, Clarisa B ^a   Day, Michael J ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAZIL; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DOG DISEASE; EPIDEMIC; GREENHOUSE EFFECT; HUMAN; INFECTION CONTROL; INSECTICIDAL ACTIVITY; NONHUMAN; PSYCHODIDAE; REMOTE SENSING; REVIEW; VACCINATION; VISCERAL LEISHMANIASIS; ANIMAL; ANIMAL DISEASE; ENDEMIC DISEASE; EVALUATION; HEALTH; LEISHMANIASIS; METHODOLOGY;

ANIMALIA; CANIS FAMILIARIS;

ANIMALS; COMMUNICABLE DISEASE CONTROL; ENDEMIC DISEASES; EPIDEMICS; HUMANS; LEISHMANIASIS; WORLD HEALTH;

EID: 80053596207     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-4-197     Document Type: Review

References (98)

1. Leishmaniasis: background information. World Health Organization, http://www.who.int/leishmaniasis/en/
2. Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil. Palatnik-de-Sousa CB, Santos WR, França-Silva JC, da Costa RT, Barbosa Reis A, Palatnik M, Mayrink W, Genaro O, Am J Trop Med Hyg 2001 65 510 517 11716106 (Pubitemid 33138167)
3. Investigations on Mediterranean Kala-azar. VI. Canine visceral leishmaniasis. Adler S, Theodor O, Proc R Soc Lond B 1932 110 402 412 10.1098/rspb.1932.0035
4. Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. le Fichoux Y, Quaranta JF, Aufeuvre JP, Lelievre A, Marty P, Suffia I, Rousseau D, Kubar J, J Clin Microbiol 1999 37 1953 1957 10325353 (Pubitemid 29235252)
5. Short report: occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors. Otero AC, da Silva VO, Luz KG, Palatnik M, Pirmez C, Fernandes O, Palatnik de Sousa CB, Am J Trop Med Hyg 2000 62 128 131 10761737 (Pubitemid 30180363)
6. Competence of the human host as a reservoir for Leishmania chagasi. Costa CH, Gomes RB, Silva MR, Garcez LM, Ramos PK, Santos RS, Shaw JJ, David JR, Maguire JH, J Infect Dis 2000 182 997 1000 10.1086/315795 10950806
7. One Health: the importance of companion animal vector-borne diseases. Day MJ, Parasit Vectors 2011 4 49 10.1186/1756-3305-4-49 21489237
8. Risk factors for human disease emergence. Taylor LH, Latham SM, Woolhouse ME, Philos Trans R Soc Lond B Biol Sci 2001 356 983 989 10.1098/rstb.2001.0888 11516376 (Pubitemid 32696243)
9. One health: the small companion animal dimension. Day MJ, Vet Record 2010 167 847 849 10.1136/vr.c6492
10. Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible & operationally achievable. Bhattacharya SK, Sur D, Sinha PK, Karbwang J, Indian J Med Res 2006 123 195 196 16778303 (Pubitemid 43905562)
11. The AFHSC-Division of GEIS Operations Predictive Surveillance Program: a multidisciplinary approach for the early detection and response to disease outbreaks. Witt CJ, Richards AL, Masuoka PM, Foley DH, Buczak AL, Musila LA, Richardson JH, Colacicco-Mayhugh MG, Rueda LM, Klein TA, Anyamba A, Small J, Pavlin JA, Fukuda MM, Gaydos J, Russell KL, the AFHSC-GEIS Predictive Surveillance Writing Group, BMC Pub Health 2009 11 Suppl 2 10
12. Control of zoonotic visceral leishmaniasis: is it time to change strategies? Tesh RB, Am J Trop Med Hyg 1995 52 287 292 7694973
13. Leishmaniasis. Burden of disease. Leishmania/HIV co-infection. World Heath Organization, http://www.who.int/leishmaniasis/burden/en/
14. Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Basset D, Faraut F, Marty P, Dereure J, Rosenthal E, Mary C, Pratlong F, Lachaud L, Bastien P, Dedet JP, Microbes Infect 2005 7 1370 1875 10.1016/j.micinf.2005.06.002 16046170 (Pubitemid 41572314)
15. The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors. Maroli M, Rossi L, Baldelli R, Capelli G, Ferroglio E, Genchi C, Gramiccia M, Mortarino M, Pietrobelli M, Gradoni L, Trop Med Int Health 2008 13 256 264 10.1111/j.1365-3156.2007.01998.x 18304273 (Pubitemid 351316978)
16. Leishmaniasis in Tuscany (Italy): VI Canine leishmaniasis in the focus of Monte Argentario (Grosseto). Pozio E, Gradoni L, Bettini S, Gramicia M, Acta Trop 1981 38 383 393 6123246 (Pubitemid 12164023)
17. Ecologie des leishmanioses dans le Sud de la France. VIII Complement a lápplication épidemiologique de la technique dí mmunofluorescence: les titres geometrices et aritmetiques moyens dans la leishmaniose canine. Lanotte G, Rioux JA, Croset H, Vollhardt Y, Ann Parasitol Hum Comp 1975 50 1 5 1099967
18. Les leishmanioses de la region provencale. Considerations epidemiologiques et ecologiques. Ranque JM, Quilici M, Dunan S, Colloques Internationaux du CNRS. Ecologie des leishmanioses Paris: Centre National de la Recherche Scientifique 1977 239 285 293
19. Canine visceral leishmaniasis in the greater Athens area, Greece. Sideris V, Karagouni E, Papadopoulou G, Garifallou A, Dotsika E, Parasite 1996 3 125 130 8758549 (Pubitemid 126431192)
20. Epidemiology of canine visceral leishmaniosis in the endemic area of Montes Claros Municipality, Minas Gerais State, Brazil. França-Silva JC, Costa RT, Siqueira AM, Machado-Coelho GLL, Costa CA, Mayrink W, Vieira EP, Costa JS, Genaro O, Nascimento E, Vet Parasitol 2003 111 161 173 10.1016/S0304- 4017(02)00351-5 12531292 (Pubitemid 36074972)
21. Canine leishmaniasis: pathological and ecological factors influencing trasmission of infection. Abranches P, Silva-Pereira MCD, Conceiçã o-Silva FM, Santana-Gomes GM, Janz JG, J Parasitol 1991 77 557 561 10.2307/3283159 1865262 (Pubitemid 23398037)
22. Canine visceral leishmaniasis in the Krenak indigenous community, Resplendor, Minas Gerais State, Brazil. Antônio EG, Malacco MAF, Gontijo CMF, Moreira EF, Caldas IS, Pena JL, Machado-Coelho GLL, Cad. Saúde Pública 2007 27 603 607 21557685
23. Seroprevalence and risk factors for canine visceral leishmaniasis in the endemic area of Dias D'Ávila, State of Bahia, Brazil. Mouta-Confort E, Lápez JA, Mendonça-Lima FW, Rev Soc Bras Med Trop 2010 43 400 404 10.1590/S0037-86822010000400013 20802939
24. The Ibizan hound presents a predominantly cellular immune response against natural Leishmania infection. Solano-Gallego L, Llull J, Ramos G, Riera C, Arboix M, Alberola J, Ferrer L, Vet Parasitol 2000 90 37 45 10.1016/S0304-4017(00)00223-5 10828510 (Pubitemid 30320808)
25. Mapping and sequencing of the canine NRAMP1 gene and identification of mutations in leishmaniasis-susceptible dogs. Altet L, Francino O, Solano-Gallego L, Renier C, Sánchez A, Infect Immun 2002 70 2763 2771 10.1128/IAI.70.6.2763-2771.2002 12010961 (Pubitemid 34564130)
26. Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism. Quinnell RJ, Kennedy LJ, Barnes A, Courtenay O, Dye C, Garcez LM, Shaw MA, Carter SD, Thomson W, Ollier WE, Immunogenetics 2003 55 23 28 12715244 (Pubitemid 36609817)
27. Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. Blackwell JM, Searle S, Mohamed H, White JK, Immunol Lett 2003 85 197 203 10.1016/S0165-2478(02)00231-6 12527228 (Pubitemid 36071576)
28. Polymorphism of Slc11a1 (Nramp1) gene and canine leishmaniasis in a case-control study. Sanchez-Robert E, Altet L, Sanchez A, Francino O, J Hered 2005 96 755 758 10.1093/jhered/esi111 16251521 (Pubitemid 41752432)
29. The immunopathology of canine vector-borne diseases. Day MJ, Parasites & Vectors 2011 4 49 10.1186/1756-3305-4-49 21994732
30. Transplacental transmission of Leishmania infantum as a means for continued disease incidence in North America. Boggiatto PM, Gibson-Corley KN, Metz K, Gallup JM, Hostetter JM, Mullin K, Petersen CA, PLoS Negl Trop Dis 2011 5 1019 10.1371/journal.pntd.0001019 21532741
31. Canine visceral leishmaniasis, United States and Canada, 2000-2003. Duprey Z, Steurer F, Rooney J, Kirchhoff L, Jackson J, Rowton E, Schantz P, Emerging Infect Dis 2006 12 440 446 16704782
32. Leishmania (Leishmania) chagasi is not vertically transmitted in dogs. Andrade HM, Toledo VPCP, Marques MJ, França Silva JC, Tafuri WL, Mayrink W, Genaro O, Vet Parasitol 2002 103 71 81 10.1016/S0304-4017(01)00552-0 11751002 (Pubitemid 34075243)
33. First report of vertical transmission of Leishmania (Leishmania) infantum in a naturally infected bitch from Brazil. da Silva SM, Ribeiro VM, Ribeiro RR, Tafuri WL, Melo MN, Michalick MSM, Vet Parasitol 2009 166 159 162 10.1016/j.vetpar.2009.08.011 19733439
34. Venereal transmission of canine visceral leishmaniasis. Silva FL, Oliveira RG, Silva TM, Xavier MN, Nascimento EF, Santos RL, Vet Parasitol 2009 160 55 59 10.1016/j.vetpar.2008.10.079 19046812
35. Transmission of visceral leishmaniasis through blood transfusions from infected English foxhounds to anemic dogs. Owens SD, Oakley DA, Marryott K, Hatchett W, Walton R, Nolan TJ, Newton A, Steurer F, Schantz P, Giger U, J Am Vet Med Assoc 2001 219 1076 1083 10.2460/javma.2001.219.1076 11700704 (Pubitemid 33607289)
36. Visceral leishmaniasis in a German child who had never entered a known endemic area: case report and review of the literature. Bogdan C, Schonian G, Banuls AL, Hide M, Pratlong F, Lorenz E, Röllinghoff M, Mertens R, Clin Infect Dis 2001 32 302 306 10.1086/318476 11170923 (Pubitemid 32524804)
37. Leishmaniasis emergence in Europe. Ready PD, Euro Surveill 2010 15 ii:19505 20403308
38. Canine leishmaniosis in the United Kingdom: a zoonotic disease waiting for a vector? Shaw SE, Langton DA, Hillman TJ, Vet Parasitol 2009 163 281 285 10.1016/j.vetpar.2009.03.025 19369005
39. Risk of infection with Leishmania spp. in the canine population in the Netherlands. Teske E, van Knapen F, Beijer EG, Slappendel RJ, Acta Vet Scand 2002 43 195 201 10.1186/1751-0147-43-195 12831172 (Pubitemid 46442250)
40. Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis. Quinnell RJ, Courtenay O, Parasitology 2009 136 1915 1934 10.1017/S0031182009991156 19835643
41. Review of exotic infectious diseases in small animals entering the United Kingdom from abroad diagnosed by PCR. Shaw S, Lerga A, Williams S, Beugnet F, Birtles R, Day M, Kenny M, Vet Rec 2003 152 176 177 10.1136/vr.152.6.176 12622289 (Pubitemid 36231407)
42. Infectious diseases. Has leishmaniasis become endemic in the USA? Enserink M, Science 2000 290 1881 1883 10.1126/science.290.5498.1881 11187042
43. Slc11a1 (formerly Nramp1) and susceptibility to canine visceral leishmaniasis. Sanchez-Robert E, Altet L, Utzet-Sadurni M, Giger U, Sanchez A, Francino O, Vet Res 2008 39 36 10.1051/vetres:2008013 18307968 (Pubitemid 351457727)
44. Control of visceral leishmaniasis in latin america-a systematic review. Romero GA, Boelaert M, PLoS Negl Trop Dis 2010 4 584 10.1371/journal.pntd. 0000584 20098726
45. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva 22-26 March 2010. World Health Organization, http://apps.who.int/tools/geoserver/www/ecomp/index.html
46. The logic of visceral leishmaniasis control. Dye C, Am J Trop Med Hyg 1996 55 125 130 8780448 (Pubitemid 26299194)
47. Studies on the control of visceral leishmaniasis: validation of the Falcon assay screening test-enzyme linked immunosorbent assay (Fast-ELISA) for field diagnosis of canine visceral leishmaniasis. Ashford DA, Badará R, Eulalio C, Freire M, Miranda C, Zalis M, David JR, Am J Trop Med Hyg 1993 48 1 8 8427377 (Pubitemid 23072556)
48. Improving methods for epidemiological control of canine visceral leishmaniasis based on a mathematical model. Impact on the incidence of the canine and human disease. Palatnik-de-Sousa CB, Melo LMB, Borja-Cabrera GP, Palatnik M, Lavor CC, An Acad Bras Cien 2004 76 583 593 10.1590/S0001- 37652004000300012 (Pubitemid 39288942)
49. Calazar na zona do Rio Doce-Minas Gerais. Resultados de medidas profiláticas. Magalhães PA, Mayrink W, Costa CA, Melo MN, Dias M, Batista SM, Michalick MSM, Williams P, Rev Inst Med Trop Sao Paulo 1980 22 197 202 7209275 (Pubitemid 11234806)
50. 2000. Natural history of Leishmania (Leishmania) chagasi infection in Northeastern Brazil: long-term follow-up. Jeronimo SM, Teixeira MJ, Sousa AD, Thielking P, Pearson RD, Evans TG, Clin Inf Dis 2000 30 608 609 10.1086/313697 (Pubitemid 30205319)
51. Controle do calazar canino: comparação dos resultados de um programa de eliminação rápida de cães sororreagentes por ensaio imuno-enzimático com outro de eliminação tardia de cães sororreagentes por teste de imunofluorescência indireta de eluato de papel filtro. Braga MD, Coelho ICB, Lima Pompeu M, Evans TG, Tavares MI, Teixeira MJ, Oliveira Lima JW, Rev Soc Bras Med Trop 1998 31 419 424 9789439
52. Cohort study on canine emigration and Leishmania infection in an endemic area for American visceral leishmaniasis. Implications for the disease control. Paranhos-Silva M, Nascimento EG, Melro MC, Oliveira GG, dos Santos WL, Pontes-de-Carvalho LC, Oliveira-dos-Santos AJ, Acta Trop 1998 69 75 83 10.1016/S0001-706X(97)00116-2 9588243 (Pubitemid 28127873)
53. Evaluation of control measures for visceral leishmaniasis (kala azar) in an endemic area in Bahia, Brazil (1995-2000). de Oliveira SS, de Araújo TM, Cad Saude Publica 2003 19 1681 1690 10.1590/S0102-311X2003000600012 14999334
54. Control of visceral leishmaniasis in urban areas: randomized factorial intervention trial. Costa CH, Tapety CM, Werneck GL, Rev Soc Bras Med Trop 2007 40 415 419 10.1590/S0037-86822007000400009 17876463 (Pubitemid 47395239)
55. Relationship between dog culling and incidence of human visceral leishmaniasis in an endemic area. Nunes CM, Pires MM, da Silva KM, Assis FD, Gonçalves Filho J, Perri SH, Vet Parasitol 2010 170 131 133 10.1016/j.vetpar.2010.01.044 20181428
56. Evaluation of 65% permethrin spot-on for prevention of canine visceral leishmaniasis: effect on disease prevalence and the vectors (Diptera: Psychodidae) in a hyperendemic area. Giffoni JH, de Almeida CE, dos Santos SO, Ortega VS, de Barros AT, Vet Ther 2002 3 485 492 12584686
57. Are insecticide-impregnated dog collars a feasible alternative to dog culling as a strategy for controlling canine visceral leishmaniasis in Brazil? Reithinger R, Coleman PG, Alexander B, Vieira EP, Assis G, Davies CR, Int J Parasitol 2004 34 55 62 10.1016/j.ijpara.2003.09.006 14711590 (Pubitemid 38056614)
58. Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil. Dietze R, Barros GB, Teixeira L, Harris J, Michelson K, Falqueto A, Corey R, Clin Infect Dis 1997 25 1240 1242 10.1086/516096 9402389 (Pubitemid 27513216)
59. Assessment of an optimized dog-culling program in the dynamics of canine Leishmania transmission. Moreira ED Jr, Mendes de Souza VM, Sreenivasan M, Nascimento EG, Pontes de Carvalho L, Vet Parasitol 2004 6 245 252 (Pubitemid 38925306)
60. Communitary assay for assessment of effectiveness of strategies for prevention and control of human visceral leishmaniasis in the municipality of Feira de Santana, State of Bahia, Brazil. De Souza VMM, Julião FS, Neves RCS, Magalhães PB, Bisinotto TV, Lima AS, de Oliveira SS, Júnior EDM, Epidemiol Serv Saude 2008 17 97 106 http://scielo.iec.pa.gov.br/scielo.php? script=sci-arttext&pid=S1679-49742008000200003&lng=pt&nrm=iso (Accessed on August 11 2011)
61. Feeding preference of Lutzomyia longipalpis (Lutz & Neiva, 1912) in transmission area of visceral leishmaniasis in Mato Grosso. Missawa NA, Lorosa ES, Dias ES, Rev Soc Bras Med Trop 2008 41 365 368 10.1590/S0037- 86822008000400008 18853008
62. Leishmaniases and the Cyprus paradox. Mazeris A, Soteriadou K, Dedet JP, Haralambous C, Tsatsaris A, Moschandreas J, Messaritakis I, Christodoulou V, Papadopoulos B, Ivovic V, Pratlong F, Loucaides F, Antoniou M, Am J Trop Med Hyg 2010 82 441 448 10.4269/ajtmh.2010.09-0282 20207870
63. An outbreak of the desert sub-type of zoonotic visceral leishmaniasis in Jiashi, Xinjiang Uygur Autonomous Region, People's Republic of China. Wang JY, Gao CH, Yang YT, Chen HT, Zhu XH, Lv S, Chen SB, Tong SX, Steinmann P, Ziegelbauer K, Zhou XN, Parasitol Int 2010 59 331 337 10.1016/j.parint.2010.04. 002 20434585
64. Present situation of visceral leishmaniasis in China. Zhi-Biao X, Parasitol Today 1989 5 224 228 10.1016/0169-4758(89)90276-7 15463223 (Pubitemid 19171777)
65. Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Alvar J, Molina R, San Andrés M, Tesouro M, Nieto J, Vitutia M, González F, San Andrés MD, Boggio J, Rodriguez F, Saniz A, Escacena C, Ann Trop Med Parasitol 1994 88 371 378 7979624 (Pubitemid 24292262)
66. Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate. Ribeiro RR, Moura EP, Pimentel VM, Sampaio WM, Silva SM, Schettini DA, Alves CF, Melo FA, Tafuri WL, Demicheli C, Melo MN, Frézard F, Michalick MS, Antimicrob Agents Chemother 2008 52 2564 2572 10.1128/AAC.00223-08 18458133 (Pubitemid 351915689)
67. Chemotherapy of Canine leishmaniosis. Baneth G, Shaw SE, Vet Parasitol 2002 106 315 324 10.1016/S0304-4017(02)00115-2 12079737 (Pubitemid 34655456)
68. Ministério da Saúde, Manual de Vigilncia e controle da Leishmaniose Visceral, 2006 12, 42 47 http://portal.saude.gov.br/portal/ arquivos/pdf/manual-leish-visceral2006.pdf
69. 2007. Multilevel modelling of the incidence of visceral leishmaniasis in Teresina, Brazil. Werneck GL, Costa CH, Walker AM, David JR, Wand M, Maguire JH, Epidemiol Infect 2007 135 195 201 10.1017/S0950268806006881 16824254 (Pubitemid 46322057)
70. Manual de Vigilncia e Controle da Leishmaniose Visceral Brasília-DF 2006 1. edição 3. reimpressão Série A. Ministério de, Saúde Secretaria de Vigilncia em Saúde Departamento de Vigilncia Epidemiolágica, 65 http://portal.saude.gov.br/ portal/arquivos/pdf/manual-leish-visceral2006.pdf
71. Vaccines for leishmaniasis in the fore coming 25 years. Palatnik-de-Sousa CB, Review Vaccine 2008 26 1709 1724 10.1016/j.vaccine.2008.01.023
72. Phase III randomized double blind clinical trial on the efficacy of a vaccine against canine visceral leishmaniasis in urban area of Montes Claros, MG, Brazil [abstract]. Genaro O, Pinto JA, Da Costa CA, França-Silva JC, Costa RT, Silva JC, Sanguinetti LSR, Vieira EP, Toledo VPCP, Mayrink W, Mem Inst Osw Cruz 1996 91 116
73. Vaccination trial against canine visceral leishmaniasis. Phocean Veterinary Study Group on Visceral Leishmaniasis. Dunan S, Frommel D, Monjour L, Ogunkolade BW, Cruz A, Quilici M, Parasite Immunol 1989 11 397 402 10.1111/j.1365-3024.1989.tb00676.x 2780090
74. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran. Mohebali M, Khamesipour A, Mobedi I, Zarei Z, Hashemi-Fesharki R, Vaccine 2004 22 4097 4100 10.1016/j.vaccine.2004.03.058 15364462 (Pubitemid 39208776)
75. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G, Vaccine 2007 25 4223 4234 10.1016/j.vaccine.2007.02.083 17395339 (Pubitemid 46661824)
76. Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas. Palatnik-de-Sousa CB, Silva-Antunes I, Morgado AA, Menz I, Palatnik M, Lavor C, Vaccine 2009 27 3505 3512 10.1016/j.vaccine.2009.03.045 19464528
77. Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein. Fernandes AP, Costa MM, Coelho EA, Michalick MS, de Freitas E, Melo MN, Luiz Tafuri W, Resende Dde M, Hermont V, Abrantes Cde F, Gazzinelli RT, Vaccine 2008 26 5888 5895 10.1016/j.vaccine.2008.05.095 18786587
78. FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine. Palatnik-de-Sousa CB, Barbosa Ade F, Oliveira SM, Nico D, Bernardo RR, Santos WR, Rodrigues MM, Soares I, Borja-Cabrera GP, Exp Rev Vaccines 2008 7 833 851 10.1586/14760584.7.6.833
79. Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis. de Lima VM, Ikeda FA, Rossi CN, Feitosa MM, Vasconcelos RO, Nunes CM, Goto H, Vet Immunol Immunopathol 2010 135 296 302 10.1016/j.vetimm.2009.12.008 20132994
80. Despite Leishvaccine and Leishmune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis. Araújo MS, de Andrade RA, Vianna LR, Mayrink W, Reis AB, Sathler-Avelar R, Teixeira-Carvalho A, Andrade MC, Mello MN, Martins-Filho AO, Vaccine 2008 26 2211 2224 10.1016/j.vaccine.2008.02.044 18395948
81. T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune. Araújo MS, de Andrade RA, Sathler-Avelar R, Teixeira-Carvalho A, Andrade MC, Vianna LR, Mayrink W, Reis AB, Malaquias LC, Mello MN, Martins-Filho OA, Vaccine 2009 27 1008 1017 10.1016/j.vaccine.2008.11. 104 19110023
82. Immunological changes in canine peripheral blood leukocytes triggered by immunization with first or second generation vaccines against canine visceral leishmaniasis. Araújo MS, de Andrade RA, Sathler-Avelar R, Magalhães CP, Carvalho AT, Andrade MC, Campolina SS, Mello MN, Vianna LR, Mayrink W, Reis AB, Malaquias LC, Rocha LM, Martins-Filho AO, Vet Immunol Immunopathol 2011 141 64 75 10.1016/j.vetimm.2011.02.007 21439654
83. A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN). da Silva VO, Borja-Cabrera GP, Correia Pontes NN, de Souza EP, Luz KG, Palatnik M, Palatnik de Sousa CB, Vaccine 2000 19 1082 1092 10.1016/S0264-410X(00)00339-X 11137242 (Pubitemid 32008272)
84. Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (São Gonçalo do Amarante, RN). Borja-Cabrera GP, Correia Pontes NN, da Silva VO, Paraguai de Souza E, Santos WR, Gomes EM, Luz KG, Palatnik M, Palatnik de Sousa CB, Vaccine 2002 20 3277 3284 10.1016/S0264-410X(02)00294-3 12213397 (Pubitemid 35251815)
85. Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs. Nogueira FS, Moreira MA, Borja-Cabrera GP, Santos FN, Menz I, Parra LE, Xu Z, Chu HJ, Palatnik-de-Sousa CB, Luvizotto MC, Vaccine 2005 23 4805 4810 10.1016/j.vaccine.2005.05.011 16011864 (Pubitemid 41242874)
86. Immunogenicity assay of the Leishmune vaccine against canine visceral leishmaniasis in Brazil. Borja-Cabrera GP, Santos FN, Bauer FS, Parra LE, Menz I, Morgado AA, Soares IS, Batista LM, Palatnik-de-Sousa CB, Vaccine 2008 26 4991 4997 10.1016/j.vaccine.2008.07.029 18675868
87. Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis. Borja-Cabrera GP, Santos FN, Santos FB, Trivellato FA, Kawasaki JK, Costa AC, Castro T, Nogueira FS, Moreira MA, Luvizotto MC, Palatnik M, Palatnik-de-Sousa CB, Vaccine 2010 28 597 603 10.1016/j.vaccine.2009.09.071 19800443
88. Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune vaccine. Santos FN, Borja-Cabrera GP, Miyashiro LM, Grechi J, Reis AB, Moreira MA, Martins Filho OA, Luvizotto MC, Menz I, Pessôa LM, Gonçalves PR, Palatnik M, Palatnik-de-Sousa CB, Vaccine 2007 25 6176 6190 10.1016/j.vaccine.2007.06.005 17630055 (Pubitemid 47090200)
89. Spread of vector-borne diseases and neglect of Leishmaniasis, Europe. Dujardin JC, Campino L, Cãavate C, Dedet JP, Gradoni L, Soteriadou K, Mazeris A, Ozbel Y, Boelaert M, Emerg Infect Dis 2008 14 1013 1018 10.3201/eid1407.071589 18598618 (Pubitemid 351920428)
90. Canine leishmaniasis: epidemiological risk and the experimental model. Moreno J, Alvar J, Trends Parasitol 2002 18 399 405 10.1016/S1471-4922(02)02347- 4 12377257
91. Environmental risk mapping of canine leishmaniasis in France. Chamaille L, Tran A, Meunier A, Bourdoiseau G, Ready P, Dedet JP, Parasit Vectors 2010 3 31 10.1186/1756-3305-3-31 20377867
92. Seroprevalence of Leishmania infantum in northwestern Spain, an area traditionally considered free of leishmaniasis. Amusategui I, Sainz A, Aguirre E, Tesouro MA, Ann N Y Acad Sci 2004 1026 154 157 10.1196/annals.1307.022 15604485 (Pubitemid 39636316)
93. Protection of dogs from the bites of phlebotomine sandflies by deltamethrin collars for the control of canine leishmaniasis. Killick-Kendrick R, Killick-Kendrick M, Focheux C, Dereure J, Puech MP, Cadiergues MC, Med Vet Entomol 1997 11 105 111 10.1111/j.1365-2915.1997.tb00298.x 9226637 (Pubitemid 27307451)
94. Evidence for an impact on the incidence of canine leishmaniasis by the use of deltamethrin-impregnated dog collars in southern Italy. Maroli M, Mizzon V, Siragusa C, D'Oorazi A, Gradoni L, Med Vet Entomol 2001 15 358 363 10.1046/j.0269-283x.2001.00321.x 11776454 (Pubitemid 34025618)
95. Evaluation of the efficacy of a topically administered combination of imidacloprid and permethrin against Phlebotomus perniciosus in dog. Mirá G, Gálvez R, Mateo M, Montoya A, Descalzo MA, Molina R, Vet Parasitol 2007 143 375 379 10.1016/j.vetpar.2006.09.014 17056182 (Pubitemid 46109180)
96. The effectiveness of a pyriprole (125 mg/ml) and a metaflumizone (150 mg/ml) combined with amitraz (150 mg/ml) spot-on treatment in preventing Phlebotomus perniciosus from feeding on dogs. Thomas C, Roques M, Franc M, Parasite 2008 15 93 96 18416253 (Pubitemid 351412863)
97. Evaluation of 65% permethrin spot-on and deltamethrin-impregnated collars for canine Leishmania infantum infection prevention. Ferroglio E, Poggi M, Trisciuoglio A, Zoon Pub Health 2008 55 145 148 10.1111/j.1863-2378.2007.01092.x (Pubitemid 351362056)
98. Effect of insecticide impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Gavgani AS, Hodjati MH, Mohite H, Davies CR, Lancet 2002 360 374 379 10.1016/S0140-6736(02)09609-5 12241778